|
 |
|
|
| |
|
Newsletter Sponsor
|
|
Lipids for Delivery of Medicinal THC/CBD Formulations
Cannabinoid based medicines are explored for treatment of many indications, including inflammatory and central nervous system disorders. Cannabinoids are poorly soluble, highly lipophilic and are poorly absorbed. There is ample evidence that lipid-based drug delivery platforms can help develop adequately dosed and age appropriate cannabinoid medicines. Gattefossé leads in lipid-based drug delivery. For starters, here is an overview of how to tackle the challenges and achieve enhanced performance in oral, topical, and mucosal drug delivery using lipid excipients.
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
